G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,792 | -74.1% | 6,800 | -55.3% | 0.00% | -50.0% |
| Q2 2023 | $37,848 | +1.6% | 15,200 | +9.4% | 0.00% | -33.3% |
| Q1 2023 | $37,252 | -76.5% | 13,900 | -52.4% | 0.00% | -72.7% |
| Q4 2022 | $158,724 | +2545.4% | 29,231 | +5253.7% | 0.01% | – |
| Q3 2022 | $6,000 | -95.3% | 546 | -97.9% | 0.00% | -100.0% |
| Q2 2022 | $129,000 | +4200.0% | 26,287 | +6891.2% | 0.01% | – |
| Q4 2021 | $3,000 | -98.1% | 376 | -96.8% | 0.00% | -100.0% |
| Q3 2021 | $157,000 | +3825.0% | 11,715 | +5323.6% | 0.01% | – |
| Q2 2021 | $4,000 | -66.7% | 216 | -70.0% | 0.00% | -100.0% |
| Q4 2020 | $12,000 | +20.0% | 720 | -17.7% | 0.00% | 0.0% |
| Q3 2020 | $10,000 | -93.6% | 875 | -85.3% | 0.00% | -93.8% |
| Q4 2019 | $157,000 | +234.0% | 5,950 | +186.3% | 0.02% | +220.0% |
| Q3 2019 | $47,000 | -21.7% | 2,078 | +78.7% | 0.01% | +25.0% |
| Q3 2018 | $60,000 | +566.7% | 1,163 | +438.4% | 0.00% | +300.0% |
| Q2 2018 | $9,000 | -87.1% | 216 | -88.6% | 0.00% | -83.3% |
| Q1 2018 | $70,000 | – | 1,890 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
| CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
| PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
| Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
| Birchview Capital, LP | 40,000 | $217 | 0.15% |
| XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
| Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
| Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
| Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |